Delivery Order SPE2DB20D3101-SPE2DB25FRMK8

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,022.80 and a period of performance ending on June 16, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,866.28 and is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes treatment medication. The contract is a firm fixed-price agreement with a performance period through June 10, 2025. There is no set-aside designation, indicating the contract was competitively awarded. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,160.08. The contract is a firm fixed price, non-set-aside delivery order that has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, to support federal healthcare requirements. The contract has a ceiling value of $2,073.72 and a performance period through June 23, 2025. It is a firm fixed price contract, with no set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,579.79 and is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract is a firm fixed price, non-set-aside award with a performance period through June 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,122.53 and a period of performance through May 14, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,022.80 and a completion date of May 22, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm-fixed-price contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corporation holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,258.60 firm fixed-price contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The delivery order has a period of performance through May 16, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The contract has a ceiling value of $1,707.40 and runs through January 11, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRMK8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes treatment medication, with a ceiling value of $1,022.80. The contract is a firm fixed-price, non-set-aside award with a completion date of June 9, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/5/25, 9:45 AM